Biotech

All Articles

Amgen records very first stage 3 win for $400M dermatitis medication

.Amgen has shared (PDF) the 1st period 3 data on its own $400 thousand dermatitis medication, linkin...

Biogen, UCB report period 3 lupus gain after neglecting earlier trial

.Biogen and also UCB's bank on advancing into stage 3 astride an unsuccessful research tries to have...

Aptadir hopes new RNA inhibitors can reverse complicated cancers cells

.Italian biotech Aptadir Rehabs has launched along with the guarantee that its pipeline of preclinic...

Wave surfs DMD results to regulatory authorities' doors, delivering stock up

.Wave Lifestyle Sciences has actually fulfilled its own goal in a Duchenne muscle dystrophy (DMD) st...

Sanofi picks brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma layer...

Achilles trickles tissue therapy program, braces for discharges after overlooking 'office practicality' targets

.Achilles Rehabs has wrecked its own method. The English biotech is actually knocking off on its own...

Aligos advertises stage 2 MASH succeed, slashing liver excess fat approximately 46%

.Aligos Therapeutics is actually heralding a midstage gain in metabolic-dysfunction connected steato...

Basilea ratings $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job developing brand new antifungals has gotten a notable boost from the U....

Capricor markets Europe liberties to late-stage DMD treatment for $35M

.Having already scooped up the USA liberties to Capricor Rehabs' late-stage Duchenne muscular dystro...

FDA junks adcomm for Applied's rare health condition medicine

.After pushing back the choice date for Applied Therapeutics' metabolic disorder medicine govorestat...